On December 19, 2024, the US Food and Drug Administration (FDA) issued a new final rule titled “Food Labeling: Nutrient Content Claims; Definition ...

By the end of March, the regulator could clear a highly anticipated pain drug from Vertex and a heart drug that’s critical to Alnylam’s future.

In a warning letter posted online late last month, the FDA scolded Viatris over a range of production slights at the ...

In a regulatory filing on Monday, Integra LifeSciences (IART) said that on December 19, 2024, a subsidiary received a warning letter from the ...

Integra Lifesciences recently received an FDA warning letter pertaining to quality systems issues at several facilities.

MALVERN, Pa., Jan. 07, 2025 (GLOBE NEWSWIRE) -- via IBN – Inc. (NYSE: ANVS) ("Annovis" or the "Company"), a late-stage ...

The U.S. Food and Drug Administration said on Friday that it has approved an injectable version of Bristol Myers Squibb's ...

The U.S. Food and Drug Administration said on Friday that it has approved an injectable version of Bristol Myers Squibb's ...

The Food and Drug Administration will change its food safety policy as 2025 progresses.  Monday’s latest is the FDA issued a notice in the Federal ...

Alleviant Medical announced that it received FDA investigational device exemption and breakthrough device designation for its ...

Researchers at Mount Sinai and Memorial Sloan Kettering believe they’ve made a breakthrough in a new form of cancer treatment ...

For decades, scientists have been trying to develop therapeutics for people living with Alzheimer’s disease, a progressive ...